<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958340/" ref="ordinalpos=3123&amp;ncbi_uid=2534177&amp;link_uid=PMC2958340" image-link="/pmc/articles/PMC2958340/figure/fig3/" class="imagepopup">Figure 3.  From: Targeting the Mechanisms of Resistance to Chemotherapy and  Radiotherapy with the Cancer Stem Cell Hypothesis. </a></div><br /><div class="p4l_captionBody">Schematic diagram of the canonical Wnt/β-catenin signaling. Wnt/β-catenin pathway may promote genomic instability after irradiation, thus allowing tumor cells to both survive after irradiation and develop additional adaptive mutations. ICG-001, PKF115-854, and CGP049040 are anticancer drugs in development that target the Wnt signaling pathway.</div></div>